panD Resolved · high auto-curated

H37Rv Rv3601c · MTBC0 mtbc0_003819 · 139 aa · 4067566–4067985 MTBC0 (-) · RefSeq NP_218118.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)aspartate 1-decarboxylase
MTBC0 PGAP re-annotationaspartate 1-decarboxylase
Revised (this work)Aspartate 1-decarboxylase. Pfam: Asp_decarbox (PF02261.23).
Functional category (TubercuList)intermediary metabolism and respiration

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 56 publications

56 TB publications mention this gene. 56 publications discuss this gene. Queried separately, 55 records carry a M. tuberculosis context and 3 a non-TB mycobacterial context (species named in the 3-record verified sample: M. smegmatis (2), M. abscessus (1)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 56: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Effects of mutations conferring pyrazinamide resistance among multidrug-resistant tuberculosis isolates from China. doi:10.1128/spectrum.00641-26 2026
Comparative transcriptomic profiling of pyrazinamide resistance in Mycobacterium tuberculosis. doi:10.1093/jambio/lxag064 2026
Design, synthesis, and biological evaluation of (E)-3-amino-N'-substituted benzylidene-6-chloropyrazine-2-carbohydrazide derivatives as anti-mycobacterial agents. doi:10.1016/j.bioorg.2025.109206 2025
Pyrazinamide kills Mycobacterium tuberculosis via pH-driven weak-acid permeation and cytosolic acidification. doi:10.1101/2025.09.26.678883 2025
Enhancing diagnostic efficiency of pyrazinamide resistance in Mycobacterium tuberculosis via modified MGIT assay and genotypic correlation. doi:10.1016/j.crmicr.2025.100462 2025
57 records returned by the alias sweep (a separate sweep from the 56 above; both are shown, neither is exhaustive)

Searched as: Rv3601c, panD, Mb3631c, ML0231, MMAR_5104, MSMEG_0021, MAB_0542 — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Effects of mutations conferring pyrazinamide resistance among multidrug-resistant tuberculosis isolates from China. doi:10.1128/spectrum.00641-26 Microbiol Spectr 2026
Comparative transcriptomic profiling of pyrazinamide resistance in Mycobacterium tuberculosis. doi:10.1093/jambio/lxag064 J Appl Microbiol 2026
Design, synthesis, and biological evaluation of (E)-3-amino-N'-substituted benzylidene-6-chloropyrazine-2-carbohydrazide derivatives as anti-mycobacterial agents. doi:10.1016/j.bioorg.2025.109206 Bioorg Chem 2025
Pyrazinamide kills Mycobacterium tuberculosis via pH-driven weak-acid permeation and cytosolic acidification. doi:10.1101/2025.09.26.678883 bioRxiv 2025
Enhancing diagnostic efficiency of pyrazinamide resistance in Mycobacterium tuberculosis via modified MGIT assay and genotypic correlation. doi:10.1016/j.crmicr.2025.100462 Curr Res Microb Sci 2025
Comprehensive evaluation of the MeltPro MTB/PZA assay for prediction of pyrazinamide resistance in multidrug-resistant tuberculosis. doi:10.1128/spectrum.02745-24 Microbiol Spectr 2025
Identification of a phenyl ester covalent inhibitor of caseinolytic protease and analysis of the ClpP1P2 inhibition in mycobacteria. doi:10.1002/mlf2.12169 mLife 2025
The epidemiology and gene mutation characteristics of pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates in Southern China. doi:10.1080/22221751.2024.2447607 Emerg Microbes Infect 2025
Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance-India, 2018-2020. doi:10.3389/fmicb.2024.1515627 Front Microbiol 2024
Genome sequencing analysis of the pncA, rpsA and panD genes responsible for pyrazinamide resistance of Mycobacterium tuberculosis from Indonesian isolates. doi:10.1111/tmi.14051 names it Trop Med Int Health 2024
A hit expansion of 3-benzamidopyrazine-2-carboxamide: Toward inhibitors of prolyl-tRNA synthetase with antimycobacterial activity. doi:10.1002/ardp.202400171 Arch Pharm (Weinheim) 2024
Prevalence, Transmission and Genetic Diversity of Pyrazinamide Resistance Among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Hunan, China. doi:10.2147/IDR.S436161 Infect Drug Resist 2024
Emerging insight of whole genome sequencing coupled with protein structure prediction into the pyrazinamide-resistance signature of Mycobacterium tuberculosis. doi:10.1016/j.ijantimicag.2023.107053 Int J Antimicrob Agents 2024
Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line. doi:10.1590/1678-4685-GMB-2022-0261 Genet Mol Biol 2023
Structure activity relationship of pyrazinoic acid analogs as potential antimycobacterial agents. doi:10.1016/j.bmc.2022.117046 Bioorg Med Chem 2022
Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis: A Review and Update. doi:10.1007/s00284-022-03032-y Curr Microbiol 2022
Structural and Mechanistic Insights into Mycobacterium abscessus Aspartate Decarboxylase PanD and a Pyrazinoic Acid-Derived Inhibitor. doi:10.1021/acsinfecdis.2c00133 names it ACS Infect Dis 2022
[Investigation of pncA, rpsA and panD Gene Mutations Associated with Resistance in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates and Spoligotyping]. doi:10.5578/mb.20229801 names it Mikrobiyol Bul 2022
Characterization of Fluoroquinolone-Resistant and Multidrug-Resistant Mycobacterium tuberculosis Isolates Using Whole-Genome Sequencing in Tianjin, China. doi:10.2147/IDR.S361635 Infect Drug Resist 2022
Insights Into Mutations Induced Conformational Changes and Rearrangement of Fe(2+) Ion in pncA Gene of Mycobacterium tuberculosis to Decipher the Mechanism of Resistance to Pyrazinamide. doi:10.3389/fmolb.2021.633365 Front Mol Biosci 2021
Mycobacterium tuberculosis PanD Structure-Function Analysis and Identification of a Potent Pyrazinoic Acid-Derived Enzyme Inhibitor. doi:10.1021/acschembio.1c00131 names it ACS Chem Biol 2021
Overcoming the Challenges of Pyrazinamide Susceptibility Testing in Clinical Mycobacterium tuberculosis Isolates. doi:10.1128/AAC.02617-20 Antimicrob Agents Chemother 2021
Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis. doi:10.1128/AAC.01916-20 Antimicrob Agents Chemother 2021
Synthesis, in vitro antibacterial activity against Mycobacterium tuberculosis, and reverse docking-based target fishing of 1,4-benzoxazin-2-one derivatives. doi:10.1002/ardp.202000199 Arch Pharm (Weinheim) 2021
Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis. doi:10.1093/cid/ciaa1509 Clin Infect Dis 2021
Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant Mycobacterium tuberculosis from Henan Province. doi:10.2147/IDR.S260161 Infect Drug Resist 2020
Mycobacterium smegmatis msmeg_3314 is involved in pyrazinamide and fluoroquinolones susceptibility via NAD(+)/NADH dysregulation. doi:10.2217/fmb-2019-0071 Future Microbiol 2020
Pyrazinamide triggers degradation of its target aspartate decarboxylase. doi:10.1038/s41467-020-15516-1 Nat Commun 2020
Detection of Novel Gene Mutations Associated with Pyrazinamide Resistance in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Southern China. doi:10.2147/IDR.S230774 Infect Drug Resist 2020
The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD. doi:10.1038/s41467-019-14238-3 names it Nat Commun 2020
Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of pncA PCR Sequencing. doi:10.1128/JCM.00145-19 J Clin Microbiol 2019
Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance. doi:10.1038/s41598-019-44013-9 Sci Rep 2019
Mycobacterium tuberculosis 6C sRNA binds multiple mRNA targets via C-rich loops independent of RNA chaperones. doi:10.1093/nar/gkz149 Nucleic Acids Res 2019
Insights into the Mechanisms of the Pyrazinamide Resistance of Three Pyrazinamidase Mutants N11K, P69T, and D126N. doi:10.1021/acs.jcim.8b00525 J Chem Inf Model 2019
Pyrazinamide drug resistance in RpsA mutant (∆438A) of Mycobacterium tuberculosis: Dynamics of essential motions and free-energy landscape analysis. doi:10.1002/jcb.28013 J Cell Biochem 2019
Pyrazinamide-resistant mycobacterium tuberculosis isolates from Khyber Pakhtunkhwa and rpsA mutations. J Biol Regul Homeost Agents 2018
Identification of Novel Mutations in LprG (rv1411c), rv0521, rv3630, rv0010c, ppsC, and cyp128 Associated with Pyrazinoic Acid/Pyrazinamide Resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.00430-18 Antimicrob Agents Chemother 2018
Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia. doi:10.1016/j.tube.2017.12.007 Tuberculosis (Edinb) 2018
'Happy the man, who, studying nature's laws, Thro' known effects can trace the secret cause.' Do we have enough pieces to solve the pyrazinamide puzzle? doi:10.1093/jac/dky060 J Antimicrob Chemother 2018
Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China. doi:10.1016/j.cmi.2017.12.012 Clin Microbiol Infect 2018
Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD. doi:10.1021/acsinfecdis.7b00079 names it ACS Infect Dis 2017
A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis. doi:10.1038/s41598-017-03452-y names it Sci Rep 2017
Molecular mechanisms of action, resistance, detection to the first-line anti tuberculosis drugs: Rifampicin and pyrazinamide in the post whole genome sequencing era. doi:10.1016/j.tube.2017.04.008 Tuberculosis (Edinb) 2017
Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.00940-17 Antimicrob Agents Chemother 2017
Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That? doi:10.1128/JCM.02532-16 J Clin Microbiol 2017
In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1. doi:10.1021/acsinfecdis.7b00017 names it ACS Infect Dis 2017
Missense Mutations in the Unfoldase ClpC1 of the Caseinolytic Protease Complex Are Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.02342-16 Antimicrob Agents Chemother 2017
Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor Synthesis. doi:10.1021/acsinfecdis.6b00070 ACS Infect Dis 2016
Molecular principles behind pyrazinamide resistance due to mutations in panD gene in Mycobacterium tuberculosis. doi:10.1016/j.gene.2016.01.024 names it Gene 2016
Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations. doi:10.1016/j.diagmicrobio.2015.10.017 names it Diagn Microbiol Infect Dis 2016
Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960. doi:10.1016/j.tube.2015.05.013 Tuberculosis (Edinb) 2015
Mechanisms of Pyrazinamide Action and Resistance. doi:10.1128/microbiolspec.MGM2-0023-2013 Microbiol Spectr 2014
Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis. doi:10.1038/emi.2014.61 names it Emerg Microbes Infect 2014
Pantothenate and pantetheine antagonize the antitubercular activity of pyrazinamide. doi:10.1128/AAC.04028-14 Antimicrob Agents Chemother 2014
Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis. doi:10.1038/emi.2013.38 names it Emerg Microbes Infect 2013
Mechanisms of Pyrazinamide Action and Resistance. doi:10.1128/microbiolspec.MGM2-0023-2013 Microbiol Spectr 2013
Expression, purification, and biochemical characterization of Mycobacterium tuberculosis aspartate decarboxylase, PanD. doi:10.1016/s1046-5928(02)00039-6 names it Protein Expr Purif 2002

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Genomic-neighbour overlap (structural caveat) co-directional · 0 % of gene

NeighbourpanC (Rv3602c, - strand)
Overlap1 bp, 0 % of this gene's length

co-directional overlap: ordinary (e.g. shared stop/start codons in an operon), not the Rv2438A-type artefact P20.1, derived from GFF3 gene coordinates, 2026-08-03.

Post-translational modifications

1 reported modified residue(s): Pyruvic acid (Ser) @25.

Experimentally reported post-translational modification(s). A phosphosite indicates the protein is expressed and is a substrate of the M. tuberculosis Ser/Thr/Tyr kinase signalling network — a regulatory context, NOT a molecular function. Source: UniProt (Modified residue features; PTM sites curated from the M. tuberculosis literature).

CRISPRi vulnerability

Vulnerability index -4.07 (95% CI -4.68 to -3.48). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionInvolved in pantothenate biosynthesis [catalytic activity: L-aspartate = beta-alanine + CO(2)].
Mycobrowser EC 4.1.1.11 · agrees with the atlas

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb3631c · 100.0% identity
M. leprae ML0231 · 82.3% identity
M. marinum MMAR_5104 · 87.3% identity
M. smegmatis MSMEG_0021 · 61.7% identity
M. orygis RJtmp_003708 · 99.3% identity
M. abscessus MAB_0542 · 76.8% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WIL3 SwissProt · reviewed · Evidence at protein level
UniProt nameAspartate 1-decarboxylase
EC (curated) EC 4.1.1.11
Curated functionCatalyzes the pyruvoyl-dependent decarboxylation of aspartate to produce beta-alanine..; FUNCTION: Overexpression of wild-type protein confers resistance to pyrazinoic acid (POA), the active form of the anti-tuberculosis prodrug pyrazinamide (PZA).

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category H Coenzyme transport and metabolism
Preferred namepanD
eggNOG descriptionCatalyzes the pyruvoyl-dependent decarboxylation of aspartate to produce beta-alanine
Orthologous groupCOG0853
EC number EC 4.1.1.11
KEGG orthology K01579
KEGG pathways map00410, map00770, map01100, map01110
KEGG modules M00119
Gene Ontology (62) GO:0003674, GO:0003824, GO:0004068, GO:0005575, GO:0005618, GO:0005622, GO:0005623, GO:0005737, GO:0005829, GO:0006082, GO:0006520, GO:0006522 +50 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.678 · quasi-invariant (3 sites), pN/pS underpowered
Polymorphic sites (≥ 0.1% of strains) 1 synonymous, 2 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

M. canettii dN/dS (deep-divergence selection) 0.341 (low power) · 2 consensus substitution(s)
low power (2 canettii-consensus substitution(s)); present in M. canettii but dN/dS not reliable
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 87.5% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 10/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 68.2%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) essential

DeJesus 2017 callES · essential
What the call meansessential: insertions absent across the whole ORF
TA sites (Himar1) 10 in the ORF — 8 in the essential state, 0 growth-defect, 2 non-essential, 0 growth-advantage. Saturation 0.200, mean read count 4. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 10 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Chemical-genetic target & druggability (PROSPECT) hypomorph tool strain

This gene is part of the PROSPECT collection of TetON transcriptional-knockdown (hypomorph) strains of essential M. tuberculosis genes, built as a sensitised background for chemical-genetic mechanism-of-action deconvolution. Being in the panel means the gene is an essential / vulnerable target for which a validated knockdown tool strain exists.

Hypomorph strainRv3601c-panD_TetOn6.3 (TetON promoter 6)
Baseline knockdown fitness2.081 median doublings (across 6 screen pool(s)) — fewer doublings = stronger growth defect on knockdown
Used in target deconvolutionyes (informs phenotypic-cluster / MOA assignment)

Panel membership reflects essentiality/vulnerability and the availability of a genetic tool, not a specific molecular function; it never changes the verdict here. Source: Bond AN et al., Nat Commun 2025;16:9673 (doi:10.1038/s41467-025-64662-x); PROSPECT chemical-genetic platform.

Proteomics (mass spectrometry) detected

MS detectiondetected in 7 of 16 independent MS datasets
Integrated abundance16.9 ppm · rank 2432/3519 (30.9th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length139 aa
Molecular weight14.9 kDa
Theoretical pI4.85
GRAVY0.147 (hydrophobic)
Aliphatic index106.7
Aromaticity0.05
Instability index8.7 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
Asp_decarboxPF02261.23 4.4e-501–113 Aspartate decarboxylase

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 2c45 (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 5 solved

PDBMethodResolutionCoverage
2c45 X-ray diffraction 2.99 Å 100%
6p02 X-ray diffraction 2.25 Å 83%
6oyy X-ray diffraction 2.7 Å 83%
6oz8 X-ray diffraction 2.7 Å 83%
6p1y X-ray diffraction 2.33 Å 82%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (5 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 94.5

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
2c45-assembly1_C 1.00 0.98 0.80 0.98 100% 81% / 100% 2.9e-20 sig 2c45-assembly1_C NATIVE PRECURSOR OF PYRUVOYL DEPENDENT ASPARTATE DECARBOXYLASE
4crz-assembly1_A 1.00 0.95 0.86 0.94 46% 90% / 99% 7.3e-17 sig 4crz-assembly1_A Direct visualisation of strain-induced protein prost-translational modification
4cs0-assembly1_A 1.00 0.94 0.85 0.93 46% 90% / 99% 1.5e-16 sig 4cs0-assembly1_A Direct visualisation of strain-induced protein post-translational modification
1pqe-assembly1_A 1.00 0.98 0.82 0.97 48% 84% / 99% 7.1e-16 sig 1pqe-assembly1_A S25A mutant of pyruvoyl dependent aspartate decarboxylase
1pt1-assembly1_A 1.00 0.98 0.81 0.96 49% 82% / 97% 2.5e-15 sig 1pt1-assembly1_A Unprocessed Pyruvoyl Dependent Aspartate Decarboxylase with Histidine 11 Mutated to Alanine

Foldseek search of the AlphaFold DB model (mean pLDDT 94.5, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 4

Upstream (5' on genome)Rv3600c (- strand, 2 bp gap)
Downstream (3' on genome)panC (- strand, -1 bp gap)
Predicted operon Rv3600c · panD · panC · Rv3603c

Neighbours from the H37Rv annotation (- strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) no multi-gene operon predicted (singleton) — disagrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT3706.1) exponential phase: operon of 4, Rv3600c · Rv3601c · Rv3602c · Rv3603c (coverage 15.59)
stationary phase: operon of 4, Rv3600c · Rv3601c · Rv3602c · Rv3603c (coverage 9.67) — agrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (6 TF) Rv0135c (represses) · mmpR5 (activates) · mftR (activates) · Rv1353c (represses) · cmtR (activates) · Rv2011c (represses)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: panC (pantothenate synthetase), high confidence (score 1000, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair is recorded in a curated database (pathway or complex membership) for M. tuberculosis genes themselves (score ≥ 200): a curated association, not a measurement in this organism.

Showing the 15 strongest of this gene's 98 partners at medium confidence (25 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 98 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv3602c panC curated pantothenate synthetase 999 1000 ctx neighborhood:882 cooccurence:678 coexpression:967 database:900 textmining:942
Rv3600c coaX type III pantothenate kinase 987 979 ctx neighborhood:882 coexpression:827 textmining:421
Rv2225 panB 3-methyl-2-oxobutanoate hydroxymethyltransferase 981 944 ctx cooccurence:581 coexpression:852 textmining:691
Rv3603c hypothetical protein 940 915 ctx neighborhood:881
Rv0768 aldA curated aldehyde dehydrogenase AldA 929 901 database:900
Rv0223c curated aldehyde dehydrogenase 929 901 database:900
Rv3293 pcd curated piperideine-6-carboxylic acid dehydrogenase 923 901 database:900
Rv0147 curated aldehyde dehydrogenase 910 901 database:900
Rv2589 gabT curated 4-aminobutyrate aminotransferase 910 900 database:900
Rv3432c gadB curated glutamate decarboxylase GadB 906 900 database:900
Rv1595 nadB curated L-aspartate oxidase 845 830 database:800
Rv0357c purA curated adenylosuccinate synthetase 810 811 database:800
Rv1380 pyrB curated aspartate carbamoyltransferase 803 804 database:800
Rv1538c ansA curated L-aparaginase 875 802 database:800
Rv1658 argG curated argininosuccinate synthase 801 802 database:800

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: aspartate 1-decarboxylase
  • MTBC0 PGAP product: aspartate 1-decarboxylase
  • Pfam (hmmscan --cut_ga): Asp_decarbox PF02261.23 (E=4e-50)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_218118.1)
  • Domains: Pfam-A via hmmscan --cut_ga — Asp_decarbox (PF02261.23)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0853
  • Curated reference: UniProt P9WIL3 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 94.5)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 98 functional partner(s); context anchor panC
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_003819|Rv3601c|panD
MLRTMLKSKIHRATVTCADLHYVGSVTIDADLMDAADLLEGEQVTIVDIDNGARLVTYAITGERGSGVIGINGAAAHLVHPGDLVILIAYATMDDARARTYQPRIVFVDAYNKPIDMGHDPAFVPENAGELLDPRLGVG